Article Details
Retrieved on: 2022-02-13 04:01:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Maryland-based Novavax, Inc. announced on February 10, 2022, that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, ...
Article found on: www.precisionvaccinations.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here